Gut Check: How Your Intestinal Macrophages Could Be Key to Understanding Lupus
"Unlocking the secrets of mucosal immunity and its connection to systemic lupus erythematosus."
Monocytes, the body's first responders, play a crucial role in initiating immune responses against pathogens and managing inflammation. Once activated, these monocytes migrate to various tissue sites, transforming into macrophages that orchestrate both innate and adaptive immune reactions.
Within the gut, mucosal macrophages are vital. They typically produce anti-inflammatory cytokines, but disruptions in this process have been increasingly linked to autoimmune diseases like systemic lupus erythematosus (SLE).
This article delves into the function of human macrophages within the intestinal environment, focusing on their role in maintaining immune homeostasis and their potential involvement in the development of SLE. Further, the significance of sex differences in intestinal macrophages and their contribution to the physiology and pathogenesis of SLE will be highlighted.
Macrophages and Gut Homeostasis
Intestinal macrophages help maintain gut homeostasis and immunity by phagocytosing antigens and supporting tolerance to self-antigens and innocuous antigens. A lupus model lacking the inhibitory Fc gamma receptor IIb (FcγRIIb) showed heightened innate immune responses involving macrophages and neutrophils. Available data on gastrointestinal manifestations in systemic lupus erythematosus are heterogeneous and largely retrospective, often based on case reports or case series.
What Role Do Intestinal Macrophages Play?
The gut's mucosal barrier, composed of the epithelium and lamina propria, is essential for maintaining overall health. Tight junctions between epithelial cells carefully regulate what enters the body. This barrier protects against harmful pathogens while allowing trace amounts of bacterial products to cross over, which is necessary to maintain systemic immune balance.
- CD14 and CD16 Expression: Human peripheral monocytes are categorized into subsets based on the presence of CD14 and CD16 markers.
- Classical Monocytes (CD14++CD16-): These are activated by Toll-like receptor (TLR) ligands like lipopolysaccharides (LPS). Once activated, they differentiate into macrophages or dendritic cells (DCs), releasing cytokines and migrating to tissues.
- Intermediate Monocytes (CD14++CD16+): Research indicates these are associated with cardiovascular diseases.
- Non-Classical Monocytes (CD14+CD16++): These monocytes primarily produce pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 when stimulated by TLR agonists. It is thought that they could be associated with autoimmune conditions.
New Views of Lupus and the Gut
Research describes crosstalk between intestinal bacteria and immune cells as important for maintaining gut homeostasis and tolerance to self-antigens and the intestinal microbiota. A 2025 single-cell atlas of intestinal epithelium in lupus offers a high-resolution view of its immune and structural environment and new insights into pathogenesis mediated by intestinal immune dysregulation. A 2024 review discusses how gut microbiome and immune-system interactions relate to systemic lupus erythematosus, with dysbiosis and gut-barrier dysfunction implicated in disease processes.
Limits of the Evidence
The interpretation of studies linking TLR7/8 activity to a leaky gut can be difficult because patients may also have higher disease activity and inflammation, which could contribute to gut leakiness independently. Human and murine intestinal microbiota differ substantially, so mouse-study findings require caution when applied to human lupus. Lupus-associated intestinal inflammation may alter the mucosal barrier, but the source describes a dynamic interaction between commensal microbes and host immunity rather than establishing a single cause.
Microbiome Differences and Study Scope
A meta-analysis reported lower gut-microbiota diversity in people with systemic lupus erythematosus than in healthy controls: the Shannon-Wiener diversity index was lower by a weighted mean difference of −0.22 (95% CI −0.32 to −0.13; p<0.001). It also found lower Chao1 richness (standardised mean difference −0.62; 95% CI −1.04 to −0.21; p=0.003). Separately, a study of small-bowel involvement included 18 female outpatients, measuring lupus activity in 10 with the Lupus Activity Criteria Count and the SLE Disease Activity Index.
The Future of Lupus Research
Macrophage-mediated tolerance and the prevention of pro-inflammatory responses to TLR ligands are essential for mucosal immunity. Altered TLR-mediated innate immune responses in intestinal macrophages may significantly contribute to SLE pathogenesis. Further studies could investigate how sex hormones affect intestinal macrophage function, gut mucosal immunity, and microbial translocation, thus improving SLE therapy.
Mapping Macrophage Research
A bibliometric study published in 2026 analyzed 1,197 articles on macrophages in systemic lupus erythematosus published from 2016 to 2025. Using Web of Science Core Collection records, it examined publication trends, collaborative networks, research themes, and the field’s knowledge base. This analysis maps the research landscape, but the supplied summary does not report specific future interventions or clinical outcomes.